CHORIOMON 5000 IE c Solv (Spritze) Durchstf 3 Stk
Details
- Manufacturer
- IBSA Institut Biochimique SA
- ATC code
- G03GA01
- Status
- 9 abgeschlossen
- Reported since
- 26 days
- First report
- 22.03.2025
- Active substance
- gonadotrophinum chorionicum
- Swissmedic no.
- 3352420
- Product information (AIPS)
- swissmedicinfo.ch →
Overview
CHORIOMON 5000 IE c Solv (Spritze) Durchstf 3 Stk is a medication by IBSA Institut Biochimique SA containing the active substance gonadotrophinum chorionicum (ATC code G03GA01). This entry is marked as resolved — the documented shortage lasted 26 days. Shortages of this active substance in Switzerland have lasted on average 15 days (measured across 1 historical cases). Switzerland has 6 other products approved with the same active substance — none are currently available.
Available alternatives
No alternatives with the same active substance are currently available.
Composition
Praeparatio cryodesiccata: gonadotrophinum chorionicum 5000 U.I. hCG, lactosum monohydricum, pro vitro. Solvens: natrii chloridum corresp. natrium 3.54 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Historical history
This product (or one with the same active substance) has already been 1× in shortage.
Frequently asked questions
What can I do if CHORIOMON 5000 IE c Solv (Spritze) Durchstf 3 Stk is unavailable?▾
Contact your pharmacy or treating physician. Substitution with a product containing the same active substance (gonadotrophinum chorionicum) is often possible. Available alternatives are listed above on this page.
What alternatives exist for CHORIOMON 5000 IE c Solv (Spritze) Durchstf 3 Stk?▾
Available alternatives with the same active substance are listed above. gonadotrophinum chorionicum is the underlying active substance — pharmacies can dispense a generic or alternative brand after consulting with the doctor.
When will CHORIOMON 5000 IE c Solv (Spritze) Durchstf 3 Stk be available again?▾
The expected delivery date — if communicated by the manufacturer — is shown in the detail section on this page. Shortages in this active-substance class typically last several weeks in Switzerland. Only the manufacturer can provide a binding forecast.
Why is CHORIOMON 5000 IE c Solv (Spritze) Durchstf 3 Stk unavailable?▾
Common reasons include manufacturing problems, active-substance shortages, quality issues, or a planned withdrawal from the Swiss market. More detailed background — when disclosed by the manufacturer — is shown in the detail section above.
Where do I report a shortage of CHORIOMON 5000 IE c Solv (Spritze) Durchstf 3 Stk?▾
Shortages are officially reported to drugshortage.ch (by manufacturers and pharmacies). Patients and treating physicians can escalate the shortage through their pharmacy — which has direct access to the reporting pipeline.
Source: drugshortage.ch · no warranty of completeness